VICTORIA PEREZ: Open Payments
NPI 1649050444 · WILDOMAR, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$278 in 9 payments from 5 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $278
Food & beverage: $278
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 3 | $147 |
| Janssen Biotech, Inc. | 2 | $43 |
| Galderma Laboratories, L.P. | 2 | $42 |
| ABBVIE INC. | 1 | $29 |
| Novartis Pharmaceuticals Corporation | 1 | $18 |
Products named: Bimzelx, TREMFYA, NEMLUVIO, RINVOQ, Rhapsido.
Industry payments across CA — which companies pay providers there.
